3-day Intensive Workshop for Prior Healthcare Compliance Certificate Program Participants
PROGRAM SCHEDULED for May 14-16, 2024 | Virtual
ABOUT PROGRAM
Seton Hall Law’s Advanced Healthcare Compliance Certificate Program (HCCP) is an intensive, three-day virtual workshop designed for experienced health care compliance and legal professionals who are looking for a deeper dive into key compliance risks, strategic decision making, and policy execution. As the advanced offering, this program builds on the substantive base offered in Seton Hall’s global foundational HCCP. The virtual format is highly participatory, with opportunities for interaction with presenters in each session and a group case study each day to enhance knowledge and application. Expert faculty include legal academics, enforcement officials, compliance professionals, and legal counsel. Attendance at each program will be limited to ensure a small group setting with ample opportunity for participant interaction with faculty and a collegial exchange of ideas. Participants will receive an Advanced HCCP Certificate upon successful completion of the program.
WHO SHOULD ATTEND
The program is designed for compliance and legal professionals who have completed one of Seton Hall Law's global compliance certificate programs (US, APAC, MidEast, LATAM, or EU). The virtual format is highly participatory, with opportunities for interaction with presenters in each session and a group case study each day to enhance knowledge and application.
Tuition cost: $3,150.00
To learn more about this program, contact Brett Canaval at [email protected] or 973-642-8382.
PROGRAM SPONSORS
Thank you to our Bronze Sponsor
PROGRAM OBJECTIVES
This intensive three (3) day program is designed to:
- Provide experienced health care compliance and legal professionals with a deeper dive into key compliance risks, strategic decision making, and policy execution
- Builds on the substantive base offered in Seton Hall’s global, foundational Health Care Compliance Certificate Programs
- Prepare attendees for positions of greater responsibility within their organizations
- Promote interactive learning and critical thinking through small group exercises and case studies
- Share strategic ideas and best practices on enterprise-level matters including ethics and culture, risk management, and influencing key business leaders
- Identify compliance challenges and opportunities in a post-COVID world
- Provide networking opportunities with other senior professionals
Program Agenda/Schedule
Day 1 Topics
- A Look Inside the Department of Justice’s Evaluation of Effective Compliance Programs Guidance
- Implementation of and Demonstrating Adherence to the Guidance
- Risk Assessment Discussion and Case Study
Day 2 Topics
- Effective, Ethics-Based Collaboration with Legal and the Business
- Third-Party Relationship Management
- Case Study: Overseas Third-Party Management
Day 3 Topics
- Deep Dive into Internal Investigations
- Compliance in a Post-COVID World and Ethical Enterprise Leadership
Compliance Certification Board (CCB) Continuing Education Units (CEUs) are currently pending and expect to be awarded based on individual attendance records.
Note: Agenda - All times are listed in Eastern Time.
Day 1: Tuesday, May 14, 2024
Program Kickoff, Overview, and Participant Introductions
Rosa M. Alves
Assistant Dean for Global Compliance & Programming, Seton Hall Law School
Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
A Look Inside the Department of Justice’s Evaluation of Effective Compliance Programs Guidance
Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
Lauren Kootman
Assistant Chief, Corporate Enforcement, Compliance & Policy Unit, Fraud Section, Criminal Division, U.S. Department of Justice
Daniel Kahn
Partner, Davis Polk
Lunch Break
Implementation of and Demonstrating Adherence to the Guidance
Gary Giampetruzzi
Partner, Litigation Department, Paul Hastings LLP
Melissa Lozner
Senior Vice President, Chief Compliance Officer,
Regeneron
Christie Camelio
Senior Vice President, Chief Compliance Officer, Insmed
Break
Risk Assessment Discussion and Case Study:
- Overview of Enterprise Risk Assessment
- Approaches to Compliance Risk Assessment
- Case Study
Christie Camelio
Senior Vice President, Chief Compliance Officer, Insmed
Edward Leskauskas
Head of US Audit, Risk Assessment, and Field Monitoring, NA Ethics & Business Integrity, Sanofi
Richard Konzelmann
Senior Manager U.S. Ethics and Business Integrity, Sanofi
Day 2: Wednesday, May 15, 2024
The New Business Ethics and Compliance Function
Piergiorgio Pepe
President, Quantum Ethics
Lawrence Platkin
Vice President and Head, U.S. Office of Compliance (Retired), Bayer U.S. LLC
Signe Elbaek
Chief Compliance Officer, Mölnlycke Health Care AB (Denmark)
Moderator: Timothy Glynn
Andrea J. Catania Endowed Professor of Law, Seton Hall Law School
Break
Third-Party Relationship Management
- Domestic and global risks, due diligence, contracting, monitoring, auditing, termination
Jaimee Reid
Senior Director, Legal Compliance, Intercept Pharmaceuticals
S. Joy Dowdle
Partner, Litigation Department, Paul Hastings LLP
Lunch Break
Case Study: Overseas Third Party Management
Jaimee Reid
Senior Director, Legal Compliance, Intercept Pharmaceuticals
S. Joy Dowdle
Partner, Litigation Department, Paul Hastings LLP
Virtual Networking Reception for All Program Faculty & Attendees
Day 3: Thursday, May 16, 2024
Compliance in a Post-COVID World and Ethical Enterprise Leadership
- Influencing business leadership, including the Board to confront compliance challenges that would emerge post-COVID
Bryant Aaron
Chief Compliance Officer, Elevance Health, Inc. (f/k/a Anthem, Inc.)
Jennifer McGee
Senior Vice President & Global Chief Compliance Officer, Otsuka Pharmaceuticals, Inc.
Moderator: Kathleen M. Boozang
Professor of Law, Seton Hall Law School
Lunch Break
Deep Dive into Internal Investigations
- Strategies, techniques, tools (analytics, etc.)
Joseph Zimmerman
Senior Vice President, Chief Compliance Officer, SpringWorks Therapeutics, Inc.
Lisa LeCointe-Cephas
Partner & Chair, Life Sciences Sector, DLA Piper
Break
Case Study
Joseph Zimmerman
Senior Vice President, Chief Compliance Officer, SpringWorks Therapeutics, Inc.
Lisa LeCointe-Cephas
Partner & Chair, Life Sciences Sector, DLA Piper
Conclusion & Closing Remarks